ACA eps in a glimpse
Analyst Rating Consensus
14
Ratings
ACA Price Target
Highest Price Target
$110.00
10% Upside
)Mean Price Target
$78.63
-21.38% Downside
)Lowest Price Target
$47.00
-53% Downside
)ACA Recent Analyst Ratings
Actual EPS vs Estimated EPS
How EPS can be helpful
Understanding the true essence of Earnings Per Share (EPS) for a company can be a complex endeavor. EPS, essentially a measure of a company's profitability on a per-share basis, is often used by investors as a barometer of financial health. However, it's crucial to recognize that EPS can be subject to manipulation through various accounting techniques and management strategies.
ACA Earnings History
After EPS - Where did the stock go?
Frequently Asked Questions
Brokerage firms have given ACA stock an average recommendation of Buy. 14 analysts have given their ratings to ACA out of which 4 analysts have given strong buy call, 9 analysts have given buy call, 1 analysts rate it hold, 0 analysts advocate strong sell call, and 0 analysts has given sell rating. The average target price of $78.63 gives the stock implied upside of roughly -21.38% over the next year or so.
Analysts suggest ACA's stock price would rise to a high of $110.00.
Within the next 12 months, analysts predict the ACA stock price could move to $47.00.
ACA stock has an average analyst estimate of $78.63.
ACA shares are currently trading -21.38% below this price target.
Its quarterly earnings per share (EPS) came in at $0.34 versus consensus estimates of $0.86, and below the comparable year-ago quarter’s EPS of $0.68.
ACA's forecasts by analysts estimating quarterly EPS at $0.76 and $7.82 for the whole year.
The analysts have projected 18.27% EPS growth for ACA in the next five years, compared to growth rates of 16.04% in the past five years.